Kathryn Wighton

new york, new york, united states

Publications:

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

About

Experienced Web Editor with a demonstrated history of working in the marketing and advertising industry. Skilled in InDesign, Editing, Content Management Systems (CMS), Online Research, and Copy Editing. Strong media and communication professional with a MS focused in Professional and Technical Communication from New Jersey Institute of Technology.

Featured Articles

Former Dentist Ordered to Pay for Unlawful Prescribing | Conexiant

The US Department of Justice announced that a federal court ordered former New Mexico dentist William C. Gardner, DDS, to pay $320,000 after finding him responsible for unlawfully issuing controlled-substance prescriptions, despite the revocation of his d... See more

conexiant.com•Kathryn Wighton•Jul 8, 2026

FDA Approves Dual-Energy Catheter Ablation Platform | Conexiant

The US Food and Drug Administration has approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform from Johnson & Johnson, an integrated catheter ablation system that enables electrophysiologists to deliver both pulsed field and radiofrequency energy ... See more

conexiant.com•Kathryn Wighton•Jul 8, 2026

FDA Approves Atacicept for IgA Nephropathy | Conexiant

The US Food and Drug Administration has granted accelerated approval to atacicept-vymj (Trutakna) for reducing proteinuria in adults with primary immunoglobulin A nephropathy who are at risk for disease progression, according to a press release from the a... See more

conexiant.com•Kathryn Wighton•Jul 7, 2026

FDA Issues CRL for Orviglance NDA | Conexiant

The US Food and Drug Administration issued a Complete Response Letter for Ascelia Pharma’s New Drug Application for Orviglance, according to a press release from the company. Ascelia said the FDA informed the company that it could not approve the applicat... See more

conexiant.com•Kathryn Wighton•Jul 6, 2026

FDA Expands Gene Therapy for Younger Patients | Conexiant

The US Food and Drug Administration has approved an expanded indication for exagamglogene autotemcel (CASGEVY) to include patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemi... See more

conexiant.com•Kathryn Wighton•Jul 2, 2026

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

LinkedIn X

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

612

Articles41

Last Article5 days ago

Stats

Education

Bachelor Of Arts, Communication, Literature at New Jersey Institute Of TechnologyGraduated: 2010

Education

Contact

Kathryn Wighton

Is this you?

About

Featured Articles

Former Dentist Ordered to Pay for Unlawful Prescribing | Conexiant

FDA Approves Dual-Energy Catheter Ablation Platform | Conexiant

FDA Approves Atacicept for IgA Nephropathy | Conexiant

FDA Issues CRL for Orviglance NDA | Conexiant

FDA Expands Gene Therapy for Younger Patients | Conexiant

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Featured Articles

Former Dentist Ordered to Pay for Unlawful Prescribing | Conexiant

FDA Approves Dual-Energy Catheter Ablation Platform | Conexiant

FDA Approves Atacicept for IgA Nephropathy | Conexiant

FDA Issues CRL for Orviglance NDA | Conexiant

FDA Expands Gene Therapy for Younger Patients | Conexiant

Social Media

Education